Please login to the form below

Not currently logged in
Email:
Password:

Apogee files two US patent applications for intradermal delivery system

Apogee Technology has filed two US provisional patent applications relating to its intradermal drug delivery technology 

US-headquartered biotech Apogee Technology has filed two US provisional patent applications relating to its intradermal drug delivery technology.  

The new patent applications describe advanced macromolecular formulations and coating methodologies.

Dr Alexander K Andrianov, Apogee's vice-president of R&D, said, "These filings are an important achievement of the company's ongoing research and development programme and are intended to protect rights for formulations with improved coating efficiency, methods and systems for precise dose control."

23rd July 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics